Purpose of Application and Description of Use: Registration of a 95mg mavacoxib tablet product for the treatment of pain and inflammation associated with degenerative joint disease in dogs, in conjunction with the approval of mavacoxib (**654/64462).
To grant the application subject to the following conditions:
Standard Conditions of Registration/Approval
Containers must meet AgVet Code Regulation 18 (Condition of Registration - All products)
Shelf Life - Label must contain an expiry date (Condition of Registration - Vet products and date controlled Ag products)
Product must not be supplied without meeting GMP Requirements (Condition of Registration - Vet products)